Weekly Roundup -
June 3, 2026
Smart. Strategic. Essential.
Unmatched Healthcare Insights from HMA,
Leavitt Partners & Wakely.
Featured:
A Summer Webinar Series: The Future of Medicaid State Directed Payments
ACCESS WEBINARTreatment-Resistant Depression: Costs, Caregiving, and Gaps in Care
READ BRIEFTrending: In Focus
Medicaid State Directed Payments: CMS Proposes Major Changes to Financing and Oversight
The Centers for Medicare & Medicaid Services (CMS) proposed changes to state directed payments mark a significant inflection point for Medicaid financing. For states, plans, and providers, the coming months will be critical in understanding the rule’s final shape—and how they can position themselves for a more constrained and standardized payment environment.
Federal Medicaid policy is entering a period of rapid change. Policymakers are advancing a series of interconnected proposals—including Medicaid community engagement (work) requirements, program integrity initiatives, and new scrutiny of financing mechanisms that shape how dollars flow through the program.
Among the most significant developments: the CMS’s proposed changes to Medicaid state directed payments (SDPs). As outlined in HMA’s recent Issue Brief, the proposal signals a meaningful shift in how federal policymakers approach provider reimbursement, managed care financing, and oversight of supplemental payment arrangements.
Health Management Associates (HMA) will further examine these developments in future articles, briefs, and its Medicaid summer webinar series, which will focus on SDPs, work requirements, and program integrity—three policy areas now moving in parallel and reshaping the Medicaid landscape. This article provides an executive overview of the SDP rule.
What are Medicaid State Directed Payments?
State directed payments (SDPs) are a key Medicaid financing tool that allows states to direct how managed care organizations reimburse providers.
States use SDPs to:
- Increase provider payment levels
- Target specific provider types or services
- Support delivery system reforms
Over time, SDPs have become a central component of Medicaid managed care financing. As the HMA issue brief emphasizes, their growing scale and complexity have drawn increased federal scrutiny.
What Does CMS Propose to Change?
The CMS proposed rule implements the statutory changes approved in the 2025 budget reconciliation act (P.L. 119-21, which CMS refers to as the Working Families Tax Cut Act, or WFTCA). The rule introduces a new framework for how SDPs are structured, regulated, and reviewed. Based on HMA’s analysis, the proposal advances several core policy shifts:
- Expanded Federal Limits on Payment Levels. CMS proposes new constraints on how much states can direct plans to pay providers, extending payment limits across a broader range of services and delivery systems. Specifically, CMS proposes to lower the payment ceiling for all SDPs to either 100 percent of Medicare for states administering Affordable Care Act (ACA) expansion programs or 110 percent of Medicare for states without an ACA expansion program. CMS plans to grandfather certain SDPs at levels above Medicare and provide a transition period with an annual 10 percent reduction until the payments are reduced to Medicare levels. In addition, this rule proposes limiting SDPs to the total published Medicare payment rate at the service level—a departure even from Medicaid fee-for-service (FFS) upper payment limits, which are limited to a reasonable estimate of what Medicare would pay but are calculated at the aggregate level by ownership class.
- Extends Limits Across Programs and Delivery Systems. The proposal seeks to align the limitations on practitioner payments under fee-for-service with the new limitations on SDPs. If a state makes payments to a subset of targeted practitioners, the new proposed limit would be actual Medicare payment rates applicable to the practitioner or provider for the same time period as the Medicaid state plan rate year. The crosswalk of Medicaid payment rates to Medicare will likely be administratively burdensome—especially for states that set Medicaid rates using an entirely different methodology than Medicare’s. Applying the Medicare payment limit at the service level will limit states’ ability to incentivize certain service types that may need enhanced reimbursement amounts to preserve access to care (e.g., primary care, neonatal, etc.).
- Broader Applicability Across Providers. The changes extend beyond a narrow set of provider types, affecting a wider range of stakeholders participating in Medicaid financing and delivery. For example, the WFTCA called for the reduced payment ceiling to be applied to the specified four classes of providers. This rule proposes that all providers be limited to the same ceiling and that the revised limits also apply to US territories.
Why Is CMS Focusing on State Directed Payments Now?
As highlighted in the HMA Issue Brief, federal policymakers are increasingly focused on the growth and complexity of SDPs as well as the role of SDPs in broader Medicaid financing strategies. In addition, CMS policy officials are prioritizing program integrity and fraud, waste, and abuse and have couched the current SDP policies as inefficient use of taxpayer dollars.
These priorities align with a broader shift toward tighter federal oversight of Medicaid funding mechanisms.
What Are the Implications for States, Plans, and Providers?
The proposed changes have wide-ranging implications across the Medicaid ecosystem.
States: SDPs have been a flexible tool for shaping payment policy and directing resources. New federal parameters may limit that flexibility and require states to reassess existing financing strategies.
Health Plans: Plans may face a more standardized and regulated environment for implementing SDP arrangements, with less variation driven by state policy choices.
Providers: Many providers rely on SDPs to supplement base Medicaid payment rates. Changes to these payments could affect reimbursement levels and financial stability, particularly for organizations serving large Medicaid populations.
As the HMA brief underscores, the impact will vary significantly by state, depending on how SDPs are currently structured.
How This Fits into Broader Medicaid Policy Changes
CMS is advancing a broader recalibration of how SDPs fit within Medicaid policy. However, the SDP proposal is also part of a larger set of federal Medicaid policy developments, including:
- Medicaid community engagement (work) requirements and other changes to eligibility and redetermination rules included in a June 1, 2026, interim final rule
- Program integrity and oversight initiatives
- Changes to financing structures and supplemental payments
Taken together, these policies signal a transition toward greater federal standardization and increased oversight of funding flows.
What Should Stakeholders Watch Next?
CMS’s proposed changes to Medicaid state directed payments mark a turning point in Medicaid financing policy.
Stakeholders should expect continued movement toward greater oversight, tighter payment parameters, and increased consistency across the program. They should begin planning now for a more constrained and standardized payment environment. Key questions center on:
- How CMS will implement and phase in payment limits across states
- The extent to which existing arrangements will be grandfathered in or phased down
- How states respond in redesigning Medicaid payment strategies
The proposed SDP rule is open for public comment through July 21, 2026, with final policy decisions expected following federal review. As pending issues are resolved, stakeholders across the Medicaid landscape will need to reassess financial models, policy approaches, and operational strategies.
Stakeholders should begin evaluating potential impacts now, as the policy direction is clear, even if final details are still evolving.
Staying Ahead of Medicaid Financing Changes
Given the pace and breadth of these developments, staying informed is critical. HMA’s upcoming Medicaid summer webinar series will provide timely analysis of the SDP proposal alongside related policy changes, including community engagement and work requirements and program integrity initiatives. These sessions are designed to help states, plans, and providers understand policy changes and prepare for operational and financial implications, identify compliance gaps, and address sustainability issues. Register for one or multiple webinars here.
To understand how these Medicaid policy changes affect your organization, contact one of HMA’s Medicaid experts.
Health-Related Social Needs in Medicaid: Opportunities Remain Despite Policy Shifts
This article was adapted based on a blog written by Laura Pence and Sara Singleton on behalf of NASDOH, an alliance managed by Leavitt Partners. NASDOH is a multi-sector coalition of stakeholders seeking to make a material improvement in the health of individuals and communities by advancing the adoption of effective policies and programs to address upstream drivers of health, such as food insecurity, housing instability, interpersonal safety, and transportation insecurity. You can find the full blog post here and learn more about the alliance at www.nasdoh.org.
Medicaid programs are the primary provider of healthcare benefits to tens of millions of Americans with limited incomes and resources, many of whom may experience food and nutrition insecurity and other health-related social needs (HRSNs), which have a significant impact on healthcare spending and health outcomes. Although more could be done, there has been bipartisan recognition in recent years that improving health outcomes and lowering healthcare costs—including in the Medicaid population—requires addressing the underlying causes of poor health outcomes.
As a result of ongoing federal and state efforts as well as private sector innovations, a growing body of evidence shows that interventions addressing nutrition, housing, and other social drivers measurably improve health outcomes and reduce costly healthcare utilization.
Medicaid Policy Context: Authorities Supporting Health-Related Social Needs
In 2021, the first Trump Administration released a letter to state health officials outlining the key authorities and consolidating state guidance around how these authorities may be used to address social needs, including:
- in lieu of services (ILOS);
- Medicaid managed care rule provisions that encourage or require Medicaid managed care organizations (MCOs) to address social needs;
- Section 1915 Home- and Community-Based Services (HCBS) waivers, which may be used to address non-medical needs of individuals to facilitate their opportunity to live and work in the community if they would otherwise need institutional care;
- 1915(i) state plan amendments that can be used to provide HCBS to people who meet state-defined needs-based criteria that are less stringent than institutional criteria; and
- Section 1115 Demonstration waivers, which provide states flexibility to address or incorporate social needs interventions into their Medicaid programs.
The Biden Administration expanded on this by issuing guidance on how states could use 1115 demonstrations – commonly called 1115 waivers – to address HRSNs in Medicaid. More than 20 states have ongoing 1115 waivers that include efforts to address HRSNs such as housing, nutrition, and employment supports. Although the 1115 waiver guidance issued during the Biden Administration have now been rescinded, 1 several underutilized opportunities to address HRSNs still exist within the Medicaid program.
Key Medicaid Opportunities to Address Health-Related Social Needs
Although 1115 waivers have become a prominent mechanism among states to advance efforts to screen for and address HRSNs, states and other stakeholders should consider previously underutilized authorities, including in lieu of services (ILOS), state plan amendments, and managed care contracts.
KFF’s Survey of Medicaid officials indicate that states are already using these tools to:
- Screen enrollees for behavioral health and social needs
- Provide referrals to social services
- Partner with community-based organizations
- Require providers to capture SDOH
States are also increasingly using ILOS to address specific needs such as nutrition, while continuing to rely on state plan amendments to expand coverage pathways for preventive services, case management, rehabilitative services, and HCBS.
As states negotiate with CMS over expiring 1115 waivers, it will be critical to consider how these alternative authorities can support continuation of interventions with demonstrated impact, including:
- The CMS Accountable Health Communities (AHC) model found that connecting Medicaid beneficiaries with unmet social needs to community resources led to a 3 percent reduction in hospitalizations, a 3 percent reduction in avoidable emergency department visits, and overall cost savings of more than $200 million.
- Research on medically tailored meals, which several states cover through Medicaid authorities including ILOS, estimates that these interventions can avert millions of hospitalizations nationally and generate net healthcare savings, while improving management of chronic conditions such as diabetes and heart disease.
- States can consider proposing new HRSN interventions within 1115 waivers. Section 1115 waivers are intended to support “experimental, pilot, or demonstration project[s],” creating an opportunity for proposing innovative interventions rather than carrying out programs that have already developed an evidence base. For interventions that already have an evidence base, funding them through the other mechanisms described will ensure continued authority to provide them.
Medicaid Innovation and Value-Based Models Continue to Support HRSN Strategies
Beyond the Medicaid-specific authorities and flexibility, the CMS Innovation Center continues to advance models that integrate HRSNs into value-based care that improves health outcomes. Building on efforts such as the AHC Model and the Medicare Advantage Value-Based Insurance Design (VBID) model, the Innovation Center has developed numerous frameworks that address HRSNs and SDOH. Upcoming models – including MAHA ELEVATE, LEAD, and ASPIRE – provide opportunities to address HRSNs.
The Innovation Center continues to provide opportunities for research and evidence gathering on screening for and addressing HRSNs as a part of value-based care. Participation in voluntary models that involve screening for and addressing HRSNs provides an opportunity for stakeholders to receive reimbursement for these activities while generating data and resources to support other entities. States, providers, and community-based organizations can participate in Innovation Center models to advance efforts that address SDOH.
Rural Health Transformation Fund
The Rural Health Transformation Fund also encourages states and stakeholders to address SDOH. The application instructions from CMS require states to describe SDOH in rural communities, including income levels, employment sectors, unemployment rates, education attainment, and availability of public transportation.
In response, many states included proposals for addressing HRSNs in rural communities. For example, Alaska’s application recognized a need for “nutrition programs addressing food insecurity and teaching healthy eating habits” and proposed to use funding to support community wellness centers to create dedicated spaces for physical activity and nutrition education. Further, Georgia proposed increasing access to nutrition services for children with autism spectrum disorder and dietitian/nutritionist support for women aged 19–44 who meet certain clinical requirements.
The Rural Health Transformation Fund (RHTF) allows states to pilot innovative interventions and address HRSNs that could later be included in the state’s Medicaid program.
Why Addressing Health-Related Social Needs Matters for Medicaid Outcomes
Opportunities to address HRSN and SDOH in Medicaid, CMMI demonstrations, and the Rural Health Transformation Fund remain significant, even as federal policy evolves. States and stakeholders have a variety of authorities and programs they can consider to address SDOH. In addition, CMS should develop more guidance on activities that align with the agency’s goals, as well as examples for states to adopt. Appropriately addressing individual social drivers of health will require collaborative and innovative approaches across the private and public sectors.
You can read the original blog post in full and learn more about the alliance at www.nasdoh.org.
Federal Policy News
Fueled By Leavitt Partners Weekly Health Intelligence
CMS Details State Requirements for Medicaid Community Engagement Compliance
On June 1, CMS released the “Establishing State Community Engagement Requirements for Certain Individuals Under Section 1902(xx) of the Social Security Act” Interim Final Rule with Comment (IFC) (CMS-2454).
Under the FY 2025 budget reconciliation law (P.L. 119-21), individuals covered under the Medicaid expansion are subject to “community engagement” requirements with statutory exceptions for individuals who are pregnant, postpartum, disabled, medically frail, American Indian or Alaska Native, parents or caregivers of young children and people with disabilities, and those who are already complying with similar requirements through the Supplemental Nutrition Assistance Program (SNAP) or the Temporary Assistance for Needy Families (TANF) program.
In the IFC, CMS defined medically frail as “an individual whose physical, mental, or other behavioral health condition significantly impairs the individual’s ability to comply with the community engagement requirement in this subpart and who is blind or disabled; with an SUD; with a disabling mental disorder; with a physical, intellectual, or developmental disability that significantly impairs their ability to perform one or more ADLs; or with a serious or complex medical condition. Individuals only need to fit within one of these categories to qualify for the medically frail exclusion to the community engagement requirement.”
CMS does not provide States with the option to add additional categories of people to the definition of medical frailty for community engagement purposes, out of concern “that there may be more of an incentive for some States to include individuals who would not reasonably be considered medically frail.”
However, the rule will permit states to accept “a statement or other information under penalty of perjury that provides sufficient information, as determined by the State, to verify an applicant or beneficiary is medically frail or otherwise has special medical needs, each time the State verifies an individual’s medical frailty” through January 1, 2028, “when there is no reliable information available to the State or the reliable information is not reasonably compatible with the information provided by or on behalf of the individual.” As such, for 2027, states may accept self-declarations from individuals that they meet the exemption for medical frailty.
Beginning on January 1, 2028, States “may only use a statement or other information provided under penalty of perjury one time during an individual’s period of enrollment, to verify eligibility as a specified excluded individual on the basis of medical frailty or having other special medical needs.”
CMS will require states to provide individuals for which they cannot verify compliance “at least” 30 days to show the state that they meet the requirement or that they are exempt, with CMS allowing states to provide more time.
Additionally, in the rule, CMS specifies the process for a State to request a temporary good faith effort exemption from compliance with timely implementation of the community engagement requirements, and the criteria by which it will evaluate such requests. CMS states that it will issue a template for states to use in submitting their requests.
States must implement the requirements by January 1, 2027, and comments are due by July 31, 2026.
OMB Proposes Major Changes to Federal Grantmaking Rules
On May 29, OMB issued a proposed rule titled, “Regulation for Federal Financial Assistance,” to make changes to the federal grantmaking process in line with previous Executive Orders (EOs) intended to ensure federal funding is used to align with the Administration’s priorities and activities and programs currently authorized by law. The proposed rule would introduce several provisions of recent EOs into federal regulation, such as requiring agencies to designate one or more senior appointees to conduct a pre-issuance review of all discretionary awards, require that discretionary awards must, where applicable, demonstrably advance the President’s policy priorities, and that “all else being equal, preference for discretionary awards should be given to institutions with lower indirect cost rates.” Additionally, the rule includes proposals to:
- Establish OMB’s authority to require agencies to submit reports detailing the specific recipients or types of recipients that received federal awards from the agency over a specific time period. OMB noted that this is to “provide OMB with oversight tools to ensure funding is not inappropriately concentrated among a narrow set of recipients.”
- Allow agencies to “consider an applicant’s history of questionable practices based on publicly available and verifiable information” and “affiliations with organizations engaged in activities that violate Federal law, undermine public safety or national security, or advocate for the overthrow of the United States Government” in awarding grants.
- Require that all discretionary federal funding opportunities (not just those that will be openly competed) be posted on Grants.gov, except when publicly announcing an opportunity would pose a national security risk, and to require the use of Statements of Interest as a part of NOFOs “when high application volume or lengthy proposals are expected.”
- Require that federal agencies or pass-through entities “must ensure that the Federal award is not used to fund, promote, encourage, subsidize, or facilitate” DEI, gender ideology, or gender transition as those terms have been defined in recent EOs.
- In the proposed rule, OMB also proposes that these OMB policies be considered a regulation rather than guidance.
Stakeholders should consider the impacts the proposed regulation could have on current funding, as well as how to respond to future NOFOs. The comment period is open until July 13 but stakeholders may consider sharing with members of Congress potential impacts of the proposed rule should it be finalized, including for their communities and districts.
White House Issues Executive Order on Childhood Vaccine Recommendations
On May 29, the White House issued an Executive Order titled, “Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developer Countries.” The EO directs the CDC and Advisory Committee on Immunization Practices (ACIP) to review the “Assessment of the U.S. Childhood and Adolescent Immunization Schedule Compared to Other Countries,” a report developed under direction of a December 2025 Presidential Memoranda and released by the HHS earlier this year. The report, authored by Dr. Tracy Beth Høeg, acting director for FDA’s Center for Drug Evaluation and Research, and Dr. Martin Kulldorff, Chief Science and Data Officer for ASPE, in consultation with experts at key agencies, stated, “The U.S. is a global outlier among peer nations in the number of target diseases included in its childhood vaccination schedule and in the total number of recommended vaccine doses.” It recommended several changes to the schedule, which were subsequently adopted by then-acting CDC Director Jim O’Neill in a decision memorandum from the heads of NIH, FDA, and CDC. This included shifting vaccines for RSV, hepatitis A, hepatitis B, and meningococcal disease from a recommendation for all children, to vaccines recommended for those at high risk. Additionally, under the revised schedule, vaccines for rotavirus, COVID-19, influenza, meningococcal disease, hepatitis A, and hepatitis B were moved to a recommendation based on “shared clinical decision-making.”
However, in March, the revised schedule was blocked by a federal district court judge, following a motion led by several public health groups, who argued that the changes to the childhood immunization schedule violate the Administrative Procedure Act, as acting CDC Director O’Neill issued the January 2026 Decision Memo without sufficiently consulting ACIP.
The EO revisits the Trump Administration’s effort to revise the childhood vaccine schedule by directing the CDC and ACIP to review the report and “the latest clinical data” and “take any appropriate steps to update the U.S. childhood and adolescent vaccine schedule,” while considering ways recommendations can provide “maximum flexibility to parents and doctors for timing and sequencing of the administration of routine immunizations.”
Further, the EO directs all executive departments and agencies to ensure that “all actions, regulations, funding, and coverage related to child and adolescent immunizations align with the schedule recommended by the ACIP and adopted by the CDC,” while explicitly stating that “all the immunizations that are in any category on the schedule recommended by the ACIP and adopted by the CDC should continue to be covered without cost sharing by private insurance and covered by Medicaid, the Children’s Health Insurance Program, and the Vaccines for Children Program.”
FDA Issues Draft Guidance on Streamlined Safety Testing for Oncology Biologics
On May 29, FDA released draft guidance titled, “Oncology Pharmaceuticals: Streamlined Nonclinical Safety Studies for Biologics and Conjugated Products,” advancing its broader effort to reduce animal testing and increase efficiency in drug development. In line with these goals, FDA is providing guidance on recommendations for general toxicology studies used for certain oncology drugs in development. The draft guidance reflects FDA analyses of historical toxicology data, as well as lessons learned from modified testing approaches used during the COVID-19 pandemic. It outlines recommendations in which traditional toxicology requirements for oncology drugs may be reduced or refined, such as using a single animal species or leveraging alternative, evidence-based approaches. These approaches may be supplemented with New Approach Methodologies (NAMs), which offer non-animal, innovative testing strategies to assess the safety and effectiveness of FDA-regulated products. The agency is seeking public input ahead of finalization, with comments due by July 30, 2026.
Ready to talk about your organization's challenges?
Schedule a ConsultationState Policy News
New York Medicaid Budget Grows to $40 Billion as State Extends Managed Care Tax
The New York Department of Health’s Medicaid budget grew to $40 billion in the budget approved by lawmakers. The fiscal 2027 spending plan also includes $1.5 billion in new Medicaid funding for healthcare facilities, including $706 million for hospitals, $480 million for nursing homes, $80 million for federally qualified health centers, and $20 million for assisted living centers. The budget makes the state’s tax on Medicaid managed care organizations permanent beginning January 1, 2027, with a uniform tax of 0.35 percent of total premium revenue, pending federal approval. However, the budget does not include specific relief for the roughly 450,000 New Yorkers expected to lose Essential Plan coverage at the start of July.
Ohio Medicaid Announces Behavioral Health Prior Authorization Standards
The Ohio Department of Medicaid announced on May 28, 2026, that it will require managed care plans to apply new statewide prior authorization standards for community behavioral health, mental health, and substance use disorder services as part of a broader program integrity initiative. The new framework will require plans to use standardized authorization forms, apply prior authorization only when services exceed defined thresholds, and improve monitoring of unusual utilization patterns. The initiative is intended to support clinical care coordination, reduce duplicative or inappropriate services, improve documentation of medical necessity, and expand value-based payment partnerships with behavioral health providers.
Oregon Secures Federal Approval for Rural Maternity Care Payments
Oregon Health Authority announced on May 28, 2026, that the Centers for Medicare & Medicaid Services (CMS) approved its state directed payment proposal to support rural maternity care services, unlocking a total investment of up to $37.5 million for 21 rural hospitals across 17 counties. The payments build on a one-time $25 million state investment authorized in 2025 and are intended to help hospitals hire or retain maternity care staff, purchase clinical equipment, and expand outreach, navigation, or perinatal supports for Oregon Health Plan members. Rural hospitals that currently offer maternity services will receive payments automatically, with Oregon Health Authority coordinating the payment schedule with coordinated care organizations and hospitals.
Pennsylvania Releases MLTSS Reprocurement RFI
The Pennsylvania Department of Human Services released on June 1, 2026, the Community HealthChoices (CHC) request for information (RFI). CHC is the state’s mandatory Medicaid managed long-term services and supports program for dually eligible individuals and individuals with physical disabilities. The previous procurement and awards were canceled by the Commonwealth Court of Pennsylvania in April 2026 following protests from managed care organizations (MCOs). The state is seeking feedback on the number of MCOs in the program, regional versus statewide breakdown, length of term, strategies to further align Medicare and Medicaid coordination, artificial intelligence, and any other program recommendations. The current incumbents are AmeriHealth Caritas, Centene, and UPMC.
Washington Releases Preliminary Medically Frail Billing Codes for Public Comment
The Washington Health Care Authority announced on May 29, 2026, that it is seeking public feedback on a set of medical billing codes and conditions to identify Medicaid enrollees that would be exempt from the Medicaid work requirements approved under the 2025 budget reconciliation act (P.L 119-21, OBBBA) due to medical frailty. Comments are due by June 19, 2026.
Private Market News
Fueled By Wakely Consulting Group
Hospitals Sue CVS for Allegedly Siphoning $250M In 340B Funds
The May 28 edition of the Wakely Wire included an article addressing lawsuits filed by hospitals owned by Mount Sinai, University of Michigan Health, and the University of Kansas accusing CVS and its pharmacy subsidiaries of manipulating reimbursement rates for 340B drugs and keeping the difference as profit. The hospitals claim CVS identified claims as 340B-eligible only after insurers had already paid full rates, then reduced hospital reimbursement through affiliated PBM and pharmacy operations. The lawsuits add to broader scrutiny of PBMs and ongoing debates over transparency and reform in the drug pricing system.
Ōura Files for IPO Amid Healthcare Push
The Wakely Wire featured coverage of potential new applications for Ōura’s wearables which already track health metrics such as temperature, heart rate, and sleep. The company is pushing further into health monitoring and working with the US Food and Drug Administration (FDA) on a study for a feature that could help identify early signs of hypertension. The IPO filing also comes as the company scales quickly: in October, Ōura said it had sold more than 5.5 million devices and expected 2025 revenue to exceed $1 billion.
Nevada to Hold Public Meeting on ‘Public Option’ 1332 Waiver Progress
The Nevada Health Authority (NVHA) announced on May 27, 2026, that it will hold a public meeting regarding the Nevada Battle Born State Plans (BBSPs) and Market Stabilization Program Section 1332 State Innovation Waiver on June 15, 2026. BBSPs are qualified health plans designed to reduce premium costs by at least 15 percent compared to reference benchmark plans over a four-year period. The Market Stabilization Program includes a state reinsurance program, targeted premium relief for some Marketplace enrollees, a quality incentive payment program, and the Practice in Nevada provider retention program. The meeting will give NVHA a platform to discuss the progress of the waiver and collect public comment.
Our Insights
Fueled By Experts Across Our HMA Companies
Health Management Associates
Proposed Changes to Medicaid State Directed Payments and Targeted Practitioner Payments
On May 20, 2026, the Centers for Medicare & Medicaid Services (CMS) released the Medicaid Managed Care State Directed Payments and Medicaid Fee-For-Service Targeted Medicaid Practitioner Payments Proposed Rule. The proposed changes to Medicaid state directed payments are highly complex. The HMA consulting team is actively analyzing the regulatory text and stands ready to assist organizations with impact evaluations, policy interpretation, and strategic response planning. To help healthcare organizations, state agencies, and health plans navigate these complex regulatory shifts, HMA experts have developed a comprehensive compliance and impact overview.
Treatment-Resistant Depression: Costs, Caregiving, and Gaps in Care
HMA’s report examines the clinical, economic, and caregiving burden of treatment-resistant depression (TRD), a condition affecting nearly one in three individuals with major depressive disorder. Drawing on a comprehensive literature review and analysis of Medicare data, the report highlights the substantial costs associated with TRD, including higher rates of hospitalization, increased healthcare utilization, and approximately $8,000 in additional annual spending per Medicare beneficiary compared to individuals with well-controlled depression.
The findings also underscore the broader economic impact, with prior research estimating that TRD accounts for tens of billions of dollars annually in national costs. In addition, the report details the significant demands placed on families and caregivers, who often provide more than 23 hours of care per week and face considerable financial and emotional strain.
A Summer Webinar Series (June 10): The Future of Medicaid State Directed Payments
As federal regulators seek to reshape the Medicaid landscape, states, providers, and insurers across the country are facing intense pressure to adapt to changing eligibility and enrollment rules and financing policies while sustaining access to services and improving outcomes. This webinar series will deliver timely analysis and actionable insights on the evolving policy and operational environment affecting Medicaid funding, enrollment, and access to services.
A Summer Webinar Series (July 15): Understanding Work and Community Engagement Requirements
This webinar series will deliver timely analysis and actionable insights on the evolving policy and operational environment affecting Medicaid funding, enrollment, and access to services. Each session will feature up-to-the-moment information and perspectives from our subject matter experts, with content tailored to reflect the latest federal guidance, waiver activity, litigation, state implementation decisions, and market developments.
A Summer Webinar Series (August 12): How New Program Integrity Expectations Affect Medicaid Payments
This webinar series will deliver timely analysis and actionable insights on the evolving policy and operational environment affecting Medicaid funding, enrollment, and access to services. Each session will feature up-to-the-moment information and perspectives from our subject matter experts, with content tailored to reflect the latest federal guidance, waiver activity, litigation, state implementation decisions, and market developments.
Ground Ambulance Payment Landscape: Challenges and Policy Options
Ground ambulance transport is a critical piece of the US healthcare infrastructure and is currently facing several challenges, threatening patient access to care. Often, at critical and tense moments before the patient reaches hospital care, ground ambulance paramedics and emergency medical technicians (EMTs) are the first point of healthcare contact for the patient. To address the challenges that the ground ambulance industry is experiencing today and lessen the impact of the various emerging issues, this report offers several recommendations for policymakers and stakeholders to consider.
Leavitt Partners
Opportunities to Address Health-Related Social Needs in Medicaid Remain Possible and Prevalent
Medicaid programs are the primary provider of healthcare benefits to tens of millions of Americans with limited incomes and resources, many of whom may experience food and nutrition insecurity and other health-related social needs (HRSNs), which have a significant impact on healthcare spending and health outcomes. Although more could be done, there has been bipartisan recognition in recent years that improving health outcomes and lowering healthcare costs—including in the Medicaid population—requires addressing the underlying causes of poor health outcomes. This blog post explores how other Medicaid authorities – beyond Section 1115 demonstrations – can be used to continue work that has an appropriate evidence base for lowering costs and improving health outcomes.
Vital Viewpoints Podcast
The Coverage Gap Grows: ACA Changes Reverberate Across Healthcare
Listen HereRFP Calendar
RFP Calendar
| Date | State/Program | Event | Beneficiaries |
|---|---|---|---|
| Date: February 2026 - DELAYED | State/Program: Illinois | Event: Awards | Beneficiaries: 2,400,000 |
| Date: June 24, 2026 | State/Program: Wisconsin LTC GSR 3 | Event: Awards | Beneficiaries: 56,000 (all GSR) |
| Date: Summer 2026 | State/Program: Illinois Foster Care | Event: RFP Release | Beneficiaries: 33,000 |
| Date: July 1, 2026 | State/Program: Hawaii Community Care Services | Event: Implementation | Beneficiaries: 5,500 |
| Date: July 28, 2026 | State/Program: Nevada Children's Specialty | Event: Awards | Beneficiaries: NA |
| Date: August 2026 | State/Program: Indiana | Event: RFP Release | Beneficiaries: 1,400,000 |
| Date: January 1, 2027 | State/Program: Illinois | Event: Implementation | Beneficiaries: 2,400,000 |
| Date: January 1, 2027 | State/Program: Nevada CO D-SNP | Event: Implementation | Beneficiaries: 88,000 |
| Date: January 1, 2027 | State/Program: Wisconsin LTC GSR 3 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: January 1, 2027 | State/Program: Illinois Tailored Care Management Program | Event: Implementation | Beneficiaries: 22,400 |
| Date: July 1, 2027 | State/Program: Nevada Children's Specialty | Event: Implementation | Beneficiaries: NA |
| Date: January 1, 2028 | State/Program: Wisconsin LTC GSR 4,6 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: Fall 2027 | State/Program: Oregon | Event: RFP Release | Beneficiaries: 1,200,000 |
| Date: 2028 | State/Program: North Carolina | Event: RFP Release | Beneficiaries: 2,200,000 |
| Date: 2029 | State/Program: California | Event: RFP Release | Beneficiaries: NA |